Revisiting the links between glycaemia, diabetes and cardiovascular disease
Open accessAbstract
Whilst the interplay between type 2 diabetes and cardiovascular disease (CVD) has been recognised for many years, recent analyses of existing studies have helped refine several aspects of this relationship with relevance to clinical practice. First, recent data demonstrate that fasting glucose is not linearly related to CVD risk in those without diabetes; rather, risk levels escalate (modestly at first) only beyond specific glucose thresholds. Consequently, glucose-based measures may not necessarily enhance CVD risk prediction in those without diabetes. Second, other data confirm that new-onset diabetes is not a post-myocardial infarction 'risk equivalent' state and that, on average, several years of diabetes duration is needed to attain this level of risk. Third, meta-analyses and systemic reviews have confirmed that diabetes increases CVD risk by around twofold on average and this risk is subject to wide variation, being lowest in those newly diagnosed and highest in those with existing vascular disease, proteinuria or renal disease. Fourth, meta-analyses of major glucose-lowering trials suggest that, whilst glucose-lowering lessens vascular risk, risk reduction arising from statins and blood pressure-lowering is greater. Fifth, statins increase diabetes risk, albeit modestly, adding to the emerging concept that some agents that primarily target CVD risk may be diabetogenic, and vice versa. Finally, arising in part from the latter observation, as well as an understanding that CVD and diabetes risk overlap in some individuals but not others, the case for combined CVD/diabetes risk screening (generally using non-fasting lipids and HbA1c), has gained strength.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A prospective cohort study found that acute pancreatitis risk increased significantly across quartiles of serum triglycerides.
“Recent data from a prospective cohort study reported that the risk of acute pancreatitis increased significantly over the quartiles of serum TGs”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [383]
Recent data indicate diabetes itself increases CVD risk about two-fold on average, with wide variation by population.
“Recent data indicate that diabetes per se increases CVD risk about two-fold on average, but the risk is subject to wide variation depending on the population. 342”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [342]
Recent data indicate that diabetes per se increases cardiovascular disease risk about two-fold on average, with wide variation depending on the population.
“Recent data indicate that diabetes per se increases CVD risk about two-fold on average, but the risk is subject to wide variation depending on the population.342”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [342]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297 · see citing works
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419 · see citing works
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888 · see citing works
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · see citing works
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000 · see citing works
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674 · see citing works
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125 · see citing works
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · see citing works
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641 · see citing works
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,489 · cited 1× · see citing works
“The long-term results of the Steno-2 study also confirm the importance of multi-factorial intervention in diabetes, with particular focus on established risk factors [24].”
BackgroundMajor lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731 · see citing works
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726 · see citing works
Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436 · see citing works
Self-citationBasal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636 · see citing works
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults
Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Coresh, J., & Brancati, F. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908359 · Cited by 1,544 · see citing works
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., Minhas, R., Sheikh, A., & Brindle, P. (2008) · BMJ · doi:10.1136/bmj.39609.449676.25 · Cited by 1,459 · see citing works
Preiss, D. (2011) · JAMA · doi:10.1001/jama.2011.860 · Cited by 1,390 · see citing works
Ray, K. K., Seshasai, S. R. K., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Preiss, D., Erqou, S., & Sattar, N. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60697-8 · Cited by 1,383 · see citing works
Self-citationIntensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189 · see citing works
Freeman, D. J., Norrie, J., Sattar, N., Neely, R. D. G., Cobbe, S. M., Ford, I., Isles, C., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.3.357 · Cited by 844 · see citing works
Self-citationLong-term follow-up after tight control of blood pressure in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Neil, H. A. W., & Matthews, D. R. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806359 · Cited by 762 · see citing works
Freeman, D. J., Norrie, J. D., CASLAKE, M. J., Gaw, A., Ford, I., Lowe, G. D. O., O’Reilly, D. S. J., Packard, C. J., Sattar, N. A., & for the West of Scotland Coronary Prevention Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.5.1596 · Cited by 720 · see citing works
Self-citationTonelli, M. A., Muntner, P., Lloyd, A. M., Manns, B., Klarenbach, S. W., Pannu, N., James, M. T., & Hemmelgarn, B. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60572-8 · Cited by 718 · see citing works
Sattar, N. A., McConnachie, A., Shaper, A. G., Blauw, G. J., Buckley, B. M., de Craen, A. J. M., Ford, I., Forouhi, N. G., Freeman, D. J., Jukema, J. W., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60602-9 · Cited by 492 · see citing works
Self-citationAffner, S. T. M. H., Ehto, S. E. L., Önnemaa, T. A. R., Yörälä, K. A. P., & Aakso, M. A. L. (1998) · Cited by 480 · see citing works
The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation
Simmons, R. K., Alberti, K. G. M. M., Gale, E. A. M., Colagiuri, S., Tuomilehto, J. O., Qiao, Q., Ramachandran, A., Tajima, N., Mirchov, I. B., Ben-Nakhi, A., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1620-4 · Cited by 459 · see citing works
Nunnelee, J. D. (2008) · Journal of Vascular Nursing · doi:10.1016/j.jvn.2008.08.002 · Cited by 407 · see citing works
Evans, J. M. M., Wang, J., & Morris, A. D. (2002) · BMJ · doi:10.1136/bmj.324.7343.939 · Cited by 384 · see citing works
for the ADVANCE Collaborative Group, Zoungas, S., Chalmers, J., Ninomiya, T., Li, Q., Cooper, M. E., Colagiuri, S., Fulcher, G., de Galan, B. E., Harrap, S., et al. (2012) · Diabetologia · doi:10.1007/s00125-011-2404-1 · Cited by 358 · see citing works
Do men develop type 2 diabetes at lower body mass indices than women?
Logue, J., Walker, J. J., Colhoun, H. M., Leese, G., Lindsay, R. S., McKnight, J. A., Morris, A. D., Pearson, D., Petrie, J. R., Philip, S., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2313-3 · Cited by 314 · see citing works
Self-citationGhouri, N., Preiss, D., & Sattar, N. A. (2010) · Hepatology · doi:10.1002/hep.23789 · Cited by 302 · see citing works
Self-citationTrends in Death Rates Among U.S. Adults With and Without Diabetes Between 1997 and 2006
Gregg, E. W., Cheng, Y. J., Saydah, S., Cowie, C. C., GARFIELD, S. A., Geiss, L. S., & Barker, L. E. (2012) · Diabetes Care · doi:10.2337/dc11-1162 · Cited by 299 · see citing works
Wannamethee, S. G., Shaper, A. G., Whincup, P. H., Lennon, L., & Sattar, N. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.2 · Cited by 281 · see citing works
Self-citationWannamethee, S. G., Papacosta, O., Lawlor, D. A., Whincup, P. H., Lowe, G. D. O., Ebrahim, S. B. J., & Sattar, N. A. (2011) · Diabetologia · doi:10.1007/s00125-011-2284-4 · Cited by 224 · see citing works
Self-citationLipid-Modifying Therapies and Risk of Pancreatitis: A Meta-analysis
Preiss, D., Tikkanen, M. J., Welsh, P., Ford, I., Lovato, L. C., Elam, M. B., LaRosa, J. C., DeMicco, D. A., Colhoun, H. M., Goldenberg, I., et al. (2012) · JAMA · doi:10.1001/jama.2012.8439 · Cited by 181 · see citing works
Self-citationSarwar, N., Aspelund, T., Eiriksdottir, G., Gobin, R., Seshasai, S. R. K., Forouhi, N. G., Sigurdsson, G., Danesh, J., & Gudnason, V. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000278 · Cited by 175 · see citing works
Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland
Looker, H. C., Nyangoma, S., Cromie, D., Olson, J. A., Leese, G., Black, M. W., Doig, J., LEE, N., Lindsay, R. S., McKnight, J. A., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2596-z · Cited by 110 · see citing works
Self-citationTrends in the Risk for Coronary Heart Disease Among Adults With Diagnosed Diabetes in the U.S.
Ford, E. S. (2011) · Diabetes Care · doi:10.2337/dc10-2251 · Cited by 104 · see citing works
Fibrates in the Treatment of Dyslipidemias — Time for a Reassessment
Goldfine, A. B., Kaul, S., & Hiatt, W. R. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1106688 · Cited by 81 · see citing works
Women develop type 2 diabetes at a higher body mass index than men
Paul, S. K., THOMAS, G. V., Majeed, A., Khunti, K. K., & Klein, K. (2012) · Diabetologia · doi:10.1007/s00125-012-2496-2 · Cited by 80 · see citing works
Simmons, R. K. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.11.1209 · Cited by 75 · see citing works
Preiss, D., Sattar, N. A., & McMurray, J. J. V. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.10.019 · Cited by 58 · see citing works
Self-citationHarron, K. L., Feltbower, R. G., McKinney, P. A., Bodansky, H. J., Campbell, F., & Parslow, R. C. (2011) · Diabetes Care · doi:10.2337/dc10-1512 · Cited by 48 · see citing works
Wannamethee, S. G., Papacosta, O., Whincup, P. H., Thomas, M. C., Carson, C., Lawlor, D. A., Ebrahim, S. B. J., & Sattar, N. A. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03171.x · Cited by 41 · see citing works
Self-citationSchöttker, B., Müller, H., Rothenbacher, D., & Brenner, H. (2012) · Diabetologia · doi:10.1007/s00125-012-2707-x · Cited by 40 · see citing works
Preiss, D., Welsh, P. I., Murray, H. M., Shepherd, J., Packard, C. J., Macfarlane, P. W., Cobbe, S. M., Ford, I., & Sattar, N. A. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq095 · Cited by 40 · see citing works
Self-citationWhy metabolic syndrome criteria have not made prime time: a view from the clinic
Sattar, N. A. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.33 · Cited by 33 · see citing works
Self-citationIntensive glucose control and cardiovascular outcomes
Guillausseau, P.-J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61481-1 · Cited by 15 · see citing works
Combined cardiovascular and diabetes risk assessment in primary care
Preiss, D., Khunti, K. K., & Sattar, N. A. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03157.x · Cited by 14 · see citing works
Self-citationIntensive glucose control and cardiovascular outcomes
Yudkin, J. S., & Richter, B. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61478-1 · Cited by 12 · see citing works
Women develop diabetes at higher BMIs than men
Sourij, H., & Holman, R. R. (2012) · Diabetologia · doi:10.1007/s00125-011-2437-5 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854 · see citing works
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162 · see citing works
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582 · see citing works
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors
Lopaschuk, G. D., & Verma, S. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.02.004 · Cited by 914 · see citing works
JBS3 Board (2014) · Heart · doi:10.1136/heartjnl-2014-305693 · Cited by 608 · see citing works
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Taskinen, M.-R., & Borén, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.039 · Cited by 440 · see citing works
SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study
Abdul‐Ghani, M. A., Prato, S. D., CHILTON, R. J., & DeFronzo, R. A. (2016) · Diabetes Care · doi:10.2337/dc16-0041 · Cited by 300 · see citing works
Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management
Sattar, N. A., & Gill, J. M. R. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00326-5 · Cited by 262 · see citing works
Self-citationPaolisso, P., Bergamaschi, L., Santulli, G., Gallinoro, E., Cesaro, A., Gragnano, F., Sardu, C., Mileva, N. B., Foà, A., Armillotta, M., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01506-8 · Cited by 208 · see citing works
Gender aspects in type 2 diabetes mellitus and cardiometabolic risk
Sattar, N. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.05.006 · Cited by 177 · see citing works
Self-citationRenal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus
Abdul‐Ghani, M. A., Norton, L., & DeFronzo, R. A. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00267.2015 · Cited by 166 · see citing works
Gonçalves, I., Bengtsson, E., Colhoun, H. M., Shore, A. C., Palombo, C., Natali, A., Edsfeldt, A., Dunér, P., Fredrikson, G. N., Björkbacka, H., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305631 · Cited by 131 · see citing works
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961 · see citing works
Verma, H., & Garg, R. (2017) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12454 · Cited by 108 · see citing works
Vazquez‐Benitez, G., DESAI, J. R., Xu, S., Goodrich, G. K., Schroeder, E. B., Nichols, G. A., Segal, J. B., Butler, M. G., Karter, A. J., Steiner, J. F., et al. (2015) · Diabetes Care · doi:10.2337/dc14-1877 · Cited by 101 · see citing works
Torella, D., Ellison, G. M., Torella, M., Vicinanza, C., Aquila, I., Iaconetti, C., Scalise, M., Marino, F., Henning, B. J., Lewis, F., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000434 · Cited by 99 · see citing works
Sattar, N. A., Ginsberg, H. N., Ray, K. K., Chapman, M. J., Arca, M., Averna, M. R., Betteridge, D. J., Bhatnagar, D., Bilianou, E., Carmena, R., et al. (2014) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2014.04.001 · Cited by 98 · see citing works
Self-citationCardiovascular Protection by Sodium Glucose Cotransporter 2 Inhibitors: Potential Mechanisms
Staels, B. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.04.009 · Cited by 92 · see citing works
Postprandial glucose spikes, an important contributor to cardiovascular disease in diabetes?
Hanssen, N. M. J., Kraakman, M. J., Flynn, M. C., Nagareddy, P. R., Schalkwijk, C. G., & Murphy, A. J. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.570553 · Cited by 90 · see citing works
Nielsen, S. H., Jonasson, L., Kalogeropoulos, K., Karsdal, M. A., Reese‐Petersen, A. L., Keller, U. A. D., Genovese, F., Nilsson, J. Å., & Gonçalves, I. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13034 · Cited by 88 · see citing works
Giorgino, F., Vora, J. P., Fenici, P., & Solini, A. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01163-9 · Cited by 85 · see citing works
Definition of intervention points in prediabetes
Ferrannini, E. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70175-x · Cited by 68 · see citing works
Quantifying cardiovascular disease risk factors in patients with psoriasis: a meta-analysis
Miller, I. M., Skaaby, T., Ellervik, C., & Jemec, G. B. E. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12490 · Cited by 67 · see citing works
Pino, A. D., Scicali, R., Calanna, S., Urbano, F., Mantegna, C., Rabuazzo, A. M., Purrello, F., & Piro, S. (2014) · Diabetes Care · doi:10.2337/dc13-2357 · Cited by 67 · see citing works
Bebu, I., Braffett, B. H., Orchard, T. J., Lorenzi, G. M., Lachin, J. M., & the DCCT/EDIC Research Group (2019) · Diabetes Care · doi:10.2337/dc18-1613 · Cited by 62 · see citing works
Pinto, T. E., Gusso, S., Hofman, P. L., Derraik, J. G. B., Hornung, T., Cutfield, W. S., & Baldi, J. C. (2014) · Diabetes Care · doi:10.2337/dc13-2031 · Cited by 59 · see citing works
Cardiovascular Protection by Sodium Glucose Cotransporter 2 Inhibitors: Potential Mechanisms
Staels, B. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.05.013 · Cited by 59 · see citing works
Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats
Carrillo-Sepúlveda, M. A., Spitler, K. M., Pandey, D., Berkowitz, D. E., & Matsumoto, T. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1318-7 · Cited by 58 · see citing works
Physical activity, ethnicity and cardio-metabolic health: Does one size fit all?
Gill, J. M. R., Celis-Morales, C. A., & Ghouri, N. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.039 · Cited by 57 · see citing works
Type 2 diabetes mellitus in France in 2012: Results from the ObEpi survey
Eschwège, É., Basdevant, A., Crine, A., Moisan, C., & Charles, M.-A. A. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.11.007 · Cited by 55 · see citing works
Derbyshire, E. J. (2014) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2014.937799 · Cited by 53 · see citing works
Macchi, C., Favero, C., Ceresa, A., Vigna, L., Conti, D. M., Pesatori, A. C., Racagni, G., Corsini, A., Ferri, N., Sirtori, C. R., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01158-6 · Cited by 51 · see citing works
Trautwein, E. A., Koppenol, W. P., de Jong, A., Hiemstra, H., Vermeer, M. A., Noakes, M., & Luscombe‐Marsh, N. D. (2018) · Nutrition and Diabetes · doi:10.1038/s41387-018-0039-8 · Cited by 49 · see citing works
Enhancing Microwave Sensor Performance With Ultrahigh Q Features Using CycleGAN
Kazemi, N., & Musı́lek, P. (2022) · IEEE Transactions on Microwave Theory and Techniques · doi:10.1109/tmtt.2022.3218015 · Cited by 48 · see citing works
Shore, A. C., Colhoun, H. M., Natali, A., Palombo, C., Östling, G., Aizawa, K., Kennbäck, C., Casanova, F., Persson, M., Gooding, K. M., et al. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12359 · Cited by 44 · see citing works
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I. M., Backer, G. D., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0157 · Cited by 41 · see citing works
Association of Baseline HbA1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58
Cahn, A., Wiviott, S. D., Mosenzon, O., Goodrich, E. L., Murphy, S. A., Yanuv, I., Rozenberg, A., Bhatt, D. L., Leiter, L. A., McGuire, D. K., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1744 · Cited by 42 · see citing works
Heydari, B., Juan, Y., Liu, H., Abbasi, S. A., Shah, R. V., Blankstein, R., Steigner, M. L., Jerosch‐Herold, M., & Kwong, R. Y. K. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.004136 · Cited by 41 · see citing works
Wang, Y., Fang, Y., Magliano, D. J., Charchar, F. J., Sobey, C. G., Drummond, G. R., & Golledge, J. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac124 · Cited by 39 · see citing works
The Role of Statins in the Treatment of Type 2 Diabetes Mellitus: An Update
Katsiki, N., Athyros, V. G., Karagiannis, A. I., & Mikhailidis, D. P. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660673 · Cited by 37 · see citing works
Wang, M.-C., Li, C., Liu, C.-S., Lin, C.-H., Yang, S.-Y., Lin, C., & Lin, C. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01421-4 · Cited by 35 · see citing works
The design and discovery of lixisenatide for the treatment of type 2 diabetes mellitus
Christensen, M., Miossec, P., Larsen, B. D., Werner, U., & Knop, F. K. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.942638 · Cited by 34 · see citing works
Afsharian, S., Akbarpour, S., Abdi, H., Sheikholeslami, F. H., Moeini, A. S. H., Khalili, D., Momenan, A. A., Azizi, F., & Hadaegh, F. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2776 · Cited by 29 · see citing works
Jovanovski, E., Duvnjak, L. S., Komishon, A., Au‐Yeung, F., Sievenpiper, J. L., Zurbau, A., Jenkins, A. L., Sung, M., Josse, R. G., Li, D., et al. (2019) · Journal of Ginseng Research · doi:10.1016/j.jgr.2019.11.005 · Cited by 31 · see citing works
Jiménez‐Cortegana, C., Iglesias, P., Ribalta, J., Vilariño‐García, T., Montánez, L., Arrieta, F., Aguilar‐Diosdado, M., Durán, S., Obaya, J. C., Becerra, A., et al. (2021) · Nutrients · doi:10.3390/nu13114150 · Cited by 31 · see citing works
Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition
Herat, L. Y., Matthews, J. R., Azzam, O., Schlaich, M. P., & Matthews, V. B. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01170-z · Cited by 30 · see citing works
COSMIC project: consensus on the objectives of the metabolic syndrome in clinic
Pedro‐Botet, J., Ascaso, J. F., Barrios, V., de la Sierra, A., Escalada, J., Millán, J., Mostaza, J. M., Pérez‐Martínez, P., Pintó, X., Salas‐Salvadó, J., et al. (2018) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s165740 · Cited by 30 · see citing works
Bittencourt, C., Piveta, V. M., Oliveira, C. S. V., Crispim, F., Meira, D. M., Saddi-Rosa, P., Giuffrida, F. M. A., & Reis, A. F. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-46 · Cited by 29 · see citing works
Statin use in Brazil: findings and implications
do Nascimento, R. C. R. M., Guerra, A. A., Jr., Álvares-Teodoro, J., Gomes, I. C., Godman, B., Bennie, M., Kurdi, A. B., & Acúrcio, F. D. A. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1451312 · Cited by 26 · see citing works
Managing dyslipidemia in patients with Type 2 diabetes
Tomlinson, B., Patil, N. G., Fok, M., & Lam, C. W. K. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1912734 · Cited by 25 · see citing works
Myocardial dysfunction and cardiovascular disease in type 2 diabetes
Ofstad, A. P. (2016) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2016.1155230 · Cited by 25 · see citing works
Bonora, E., & CIGOLINI, M. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.03.002 · Cited by 25 · see citing works
Diabetes is associated with decreased migraine risk: A nationwide cohort study
Antonazzo, I. C., Riise, T., Cortese, M., Berge, L. I., Engeland, A., Fasmer, O. B., Lund, A., Ødegaard, K. J., Poluzzi, E., & Bjørnevik, K. (2017) · Cephalalgia · doi:10.1177/0333102417748573 · Cited by 24 · see citing works
Kalantzi, K., Tentolouris, N., Melidonis, A. J., Papadaki, S., Peroulis, M., Amantos, K. A., Andreopoulos, G., Bellos, G., Boutel, D., Bristianou, M., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018184 · Cited by 24 · see citing works
Giorgino, F., Vora, J., Fenici, P., & Solini, A. (2020) · Diabetes, obesity and metabolism · doi:10.1111/dom.14055 · Cited by 19 · see citing works
Shao, H., Shi, L., Lin, Y., & Fonseca, V. A. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108316 · Cited by 23 · see citing works
Chen, Y., Fu, Y., Wang, S., Chen, P., Pei, Y., Zhang, J., Zhang, R., Niu, G., Gu, F., & Li, X. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01668-5 · Cited by 23 · see citing works
Mortensen, M. B., Kulenovic, I., & Falk, E. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0400-y · Cited by 23 · see citing works
Alsaidan, A. A. (2025) · International Journal of Clinical Practice · doi:10.1155/ijcp/7233591 · Cited by 22 · see citing works
Present status of statin therapy
Opie, L. H. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.10.002 · Cited by 22 · see citing works
Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros
Makrilakis, K., & Liatis, S. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8927473 · Cited by 21 · see citing works
Polanka, B. M., Berntson, J., Vrany, E. A., & Stewart, J. C. (2018) · Annals of Behavioral Medicine · doi:10.1093/abm/kay007 · Cited by 21 · see citing works
The effect of the experimental chronic hyperglycemia on the kidney and myocardium
Yarmolenko, O. S., Бумейстер, В. І., Polák, Š., Gordienko, O., Prykhodko, O., Demikhova, N. V., Shkatula, Y. V., & Demikhov, A. (2021) · Ukrainian Journal of Nephrology and Dialysis · doi:10.31450/ukrjnd.3(71).2021.01 · Cited by 20 · see citing works
Mattina, A., Argano, C., Brunori, G., Lupo, U., Raspanti, M., Monaco, M. L., Bocchio, R. M., Natoli, G., Giusti, M. A., & Corrao, S. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.09.008 · Cited by 20 · see citing works
Hua, X.-P., Qian, J., Cao, C., Xie, J., Zeng, X., & Zhang, Z. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15037292 · Cited by 21 · see citing works
Anholm, C., Kumarathurai, P., Pedersen, L. R., Nielsen, O. W., Kristiansen, O. P., Fenger, M., Madsbad, S., Sajadieh, A., & Haugaard, S. B. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12891 · Cited by 20 · see citing works
Vora, J. P., Cherney, D. Z. I., Kosiborod, M., Spaak, J., Kanumilli, N., Khunti, K. K., Lam, C. S. P., Bachmann, M., Fenici, P., & the CaReMe Global Alliance (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15485 · Cited by 19 · see citing works
Nichols, G. A., Rosales, A. G., Perrin, N., & Fortmann, S. P. (2013) · Diabetes Care · doi:10.2337/dc13-1300 · Cited by 19 · see citing works
Hill, J., Peer, N., Jonathan, D., Mayige, M. T., Sobngwi, E., & Kengne, A. P. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17082876 · Cited by 19 · see citing works
Hashemi‐Madani, N., Ismail‐Beigi, F., Khamseh, M. E., Malek, M., & Valojerdi, A. E. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317707293 · Cited by 18 · see citing works
A dysglycaemic effect of statins in diabetes: relevance to clinical practice?
Swerdlow, D. I., & Sattar, N. A. (2014) · Diabetologia · doi:10.1007/s00125-014-3409-3 · Cited by 17 · see citing works
Self-citationEctopic calcification in diabetic vascular disease
Avogaro, A., Rattazzi, M., & Fadini, G. P. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.894021 · Cited by 17 · see citing works
Postprandial hyperlipidemia as a risk factor in patients with type 2 diabetes
Tomlinson, B., Chan, P., & Lam, C. W. K. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1750949 · Cited by 17 · see citing works
Systematic Literature Review of Transformer Model Implementations in Detecting Depression
Nanggala, K., Elwirehardja, G. N., & Pardamean, B. (2023) · International Conference of Computer and Informatics Engineering (IC2IE) · doi:10.1109/ic2ie60547.2023.10331448 · Cited by 16 · see citing works
Empagliflozin as a new management strategy on outcomes in patients with type 2 diabetes mellitus
Салухов, В. В., & Demidova, T. Y. (2016) · Diabetes Mellitus · doi:10.14341/dm8216 · Cited by 16 · see citing works
Lessons from SAVOR and EXAMINE: Some important answers, but many open questions
Schernthaner, G., & Sattar, N. A. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.02.011 · Cited by 15 · see citing works
Self-citationAn overview of alogliptin + pioglitazone for the treatment of type 2 diabetes
Tomlinson, B., Chan, P., & Lam, C. W. K. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1985465 · Cited by 16 · see citing works
Kang, S.-J., & Ahn, C.-H. (2019) · Journal of Exercise Rehabilitation · doi:10.12965/jer.1938362.181 · Cited by 12 · see citing works
Ren, J., Zhang, H., Shao, X., Gu, T., Hu, S., Zhang, Y., Jiang, C. Q., Zhang, J., Wu, X., Liu, X., et al. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133352 · Cited by 12 · see citing works
Dauriz, M., Porneala, B., Guo, X., Bielak, L. F., Peyser, P. A., Durant, N. H., Carnethon, M. R., Bonadonna, R. C., Bonora, E., Bowden, D. W., et al. (2015) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000740 · Cited by 12 · see citing works
Başaran, Ö. (2023) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2022.2012 · Cited by 11 · see citing works
Cardiometabolic medicine: time to recognize a new clinical specialty?
Krentz, A. J., & Jacob, S. (2019) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000173 · Cited by 11 · see citing works
Lim, L., Lau, E. S. H., Kong, A. P. S., Fu, A. W. C., Lau, V., Jia, W., Sheu, W. H., Sobrepeña, L., Yoon, K., Tan, A. T. B., et al. (2022) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2022.100663 · Cited by 11 · see citing works
Joung, K. H., Kim, J. M., Choung, S., Lee, J. H., Kim, H. J., & Ku, B. J. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.01.17 · Cited by 10 · see citing works
Ali, M. K., Singh, K., Kondal, D., Devarajan, R., Patel, S. A., Menon, V. U., Varthakavi, P. K., Vishwanathan, V., Dharmalingam, M., Bantwal, G., et al. (2024) · PLOS Medicine · doi:10.1371/journal.pmed.1004335 · Cited by 10 · see citing works
Scheen, A. J. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101508 · Cited by 10 · see citing works
Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2025
Rached, F. H., Miname, M. H., Rocha, V. Z., Zimerman, A., Cesena, F. Y., Sposito, A. C., Santos, R. D., Behr, P. E. B., Bianco, H. T., Alves, R. J., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250640 · Cited by 45 · see citing works
Gimeno-Orna, J. A., Lamarca, Y. B., Campos-Gutiérrez, B., Molinero-Herguedas, E., Lou-Arnal, L. M., & García-García, B. (2015) · Nefrología · doi:10.1016/j.nefro.2015.05.025 · Cited by 9 · see citing works
Possible Mechanisms of Action of SGLT2 Inhibitors in Heart Failure
Martins, C. N. G., Bau, A. A., da Silva, L. M., & Coelho‐Filho, O. R. (2021) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20210007 · Cited by 9 · see citing works
Cardiovascular Safety of New Drugs for Diabetes: Getting the Balance Right?
Krentz, A. J., & Hompesch, M. (2014) · Pharmaceutical Medicine · doi:10.1007/s40290-014-0053-7 · Cited by 9 · see citing works
Merton, K., Davies, M. J., Vijapurkar, U., Inman, D., & Meininger, G. E. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1391759 · Cited by 9 · see citing works
Ilundain-González, A. I., Gimeno-Orna, J. A., Sáenz-Abad, D., Pons-Dolset, J., Hoyo, J. C.-D., & Lahoza-Pérez, M. C. (2018) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2018.01.005 · Cited by 9 · see citing works
Sakanaka, A., Katakami, N., Furuno, M., Nishizawa, H., Omori, K., Taya, N., Ishikawa, A., Mayumi, S., Inoue, M., Isomura, E. T., et al. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1074285 · Cited by 8 · see citing works
Liu, C., Luo, B., Wang, B., He, L. N., Wu, H., Hou, L., & Zhang, K. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-22407-z · Cited by 8 · see citing works
Talenezhad, N., Hosseinzadeh, M., Rahmanian, M., Mirzavandi, F., Karimi‐Nazari, E., & Mozaffari–Khosravi, H. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100230 · Cited by 7 · see citing works
Claro, A. E., Palanza, C., Mazza, M., Corsello, A., Rizzi, A., Tartaglione, L., de Waure, C., Marano, G., Piciollo, S., Schuenemann, G. E. U. M., et al. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01993-x · Cited by 8 · see citing works
Are diabetes guidelines truly evidence based?
Bouchonville, M. F., Matani, S., DuBroff, J. J., & DuBroff, R. J. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.02.035 · Cited by 7 · see citing works
Krajnc, M., Balon, B. P., & Krajnc, I. (2019) · Journal of International Medical Research · doi:10.1177/0300060518814080 · Cited by 8 · see citing works
Iwamoto, M., Kubota, T., Sakurai, Y., Wada, N., Shioda, S., Yamauchi, T., Kadowaki, T., & Kubota, N. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.971 · Cited by 6 · see citing works
Piveta, V. M., Bittencourt, C., Oliveira, C. S. V., Saddi-Rosa, P., Meira, D. M., Giuffrida, F. M. A., & Reis, A. F. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-138 · Cited by 7 · see citing works
- Authors
- Sattar, N.
- Affiliations
- University of Glasgow (GB)
- Corresponding author
- Sattar, N.
- ORCID
- Sattar, N.
- Venue
- Diabetologia
- Published
- 2013-01-27
- Volume
- 56
- Issue
- 4
- Pages
- 686-695
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2031027166
- Cited by
- 163
- References
- 52
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 4 · 2023: 8 · 2022: 17 · 2021: 11 · 2020: 14 · 2019: 15 · 2018: 13 · 2017: 10 · 2016: 16 · 2015: 16 · 2014: 25 · 2013: 7
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- British Heart Foundation
- Diabetes UK
- University College London
- University of Glasgow
- University of Bristol
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, cardiovascular disease, glycemia, fasting blood glucose, cardiovascular risk prediction, new-onset diabetes, myocardial infarction, diabetes duration, proteinuria, kidney disease, vascular disease, glucose-lowering therapy, statins, diabetogenic effect, HbA1c
- MeSH terms
- Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Hyperglycemia, Male, Risk Factors, Sex Factors, Triglycerides, Meta-Analysis as Topic, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
